Trial Profile
β3 adrenergic agoniSt treatment in chronic Pulmonary HypERtEnsion secondary to heart failure: a randomized placebo-controlled phase 2 clinical trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2017
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Heart failure; Pulmonary hypertension
- Focus Therapeutic Use
- 29 Mar 2017 New trial record